Oppenheimer Oncology Summit

Please join us for the Oppenheimer Oncology Summit, in partnership with The University of Texas MD Anderson Cancer Center, for a day of faculty presentations, panels, and networking.

Next-Generation Approaches for Tailoring Lung Cancer Therapeutics with John Heymach, Chair of Thoracic-Head & Neck Medical Oncology at MDACC

Speaker: John V. Heymach, M.D., Ph.D.

---

Discussion on Novel and Emerging Epigentic Approaches to Solid and Heme Malignancies

Moderator: Leland Gershell, M.D., Ph.D., Managing Director and Senior Analyst, Biopharmaceuticals
Speakers: Philip Jones, Ph.D. and Andy Futreal, B.S., Ph.D.

---

Next-level Targeted Oncology – Discussing Pan-RAS/MAPK Inhibition Strategies

Moderator: Hartaj Singh, Managing Director and Senior Analyst, Biotechnology
Speakers: Macelo Vailati Negrao, MD,, Ferdinandos Skoulidis, M.D., Ph.D., MCRP, and David S. Hong, MD

---

Discussion on Leveraging Synthetic Lethality for the Development of Novel Treatments Beyond PARP Inhibitors

Moderator: Matt Biegler, Senior Analyst, Emerging Biotechnology
Speaker: Timothy Yap, MBBS, PhD, FRCP

---

Discussion on Targeted Delivery of Tumor Killing Agents ADCs and RLTs

Moderators: Jay Olson, Managing Director and Senior Analyst, Biotechnology and Jeff Jones, Managing Director and Senior Analyst, Biotechnology
Speakers: H. Charles Manning, Ph.D. and Funda Meric-Bernstam, MD

---

Exciting & Practice Changing Advances in Metastatic Breast Cancer- A Discussion

Moderator: Hartaj Singh, Managing Director and Senior Analyst, Biotechnology
Speaker: Clinton Yam, M.D., M.S.

For institutional investors only.
Please contact your Oppenheimer institutional sales representative for more information.